Pathology and genetics of hereditary colorectal cancer
H Ma, LAA Brosens, GJA Offerhaus, FM Giardiello… - Pathology, 2018 - Elsevier
Colorectal cancer (CRC) accounts for over 8% of all deaths annually worldwide. Between 2
and 5% of all CRCs occur due to inherited syndromes, including Lynch syndrome, familial …
and 5% of all CRCs occur due to inherited syndromes, including Lynch syndrome, familial …
[HTML][HTML] Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis
Purpose Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC)
syndrome, with an estimated prevalence of 2% to 3% of CRC. A prevalence study is needed …
syndrome, with an estimated prevalence of 2% to 3% of CRC. A prevalence study is needed …
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal …
V Piñol, A Castells, M Andreu, S Castellví-Bel… - Jama, 2005 - jamanetwork.com
ContextThe selection of individuals for hereditary nonpolyposis colorectal cancer (HNPCC)
genetic testing is challenging. Recently, the National Cancer Institute outlined a new set of …
genetic testing is challenging. Recently, the National Cancer Institute outlined a new set of …
Prediction of germline mutations and cancer risk in the Lynch syndrome
ContextIdentifying families at high risk for the Lynch syndrome (ie, hereditary nonpolyposis
colorectal cancer) is critical for both genetic counseling and cancer prevention. Current …
colorectal cancer) is critical for both genetic counseling and cancer prevention. Current …
Microsatellite instability and the clinicopathological features of sporadic colorectal cancer
R Ward, A Meagher, I Tomlinson, T O'connor, M Norrie… - Gut, 2001 - gut.bmj.com
BACKGROUND AND AIMS In this study, we prospectively examined the clinical significance
of the microsatellite instability (MSI) phenotype in sporadic colorectal cancer, and …
of the microsatellite instability (MSI) phenotype in sporadic colorectal cancer, and …
The cancer immunotherapy biomarker testing landscape
EE Walk, SL Yohe, A Beckman… - … of pathology & …, 2020 - meridian.allenpress.com
Context.—Cancer immunotherapy provides unprecedented rates of durable clinical benefit
to late-stage cancer patients across many tumor types, but there remains a critical need for …
to late-stage cancer patients across many tumor types, but there remains a critical need for …
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas
JM Cunningham, CY Kim, ER Christensen… - The American Journal of …, 2001 - cell.com
A comprehensive analysis of somatic and germline mutations related to DNA mismatch–
repair (MMR) genes can clarify the prevalence and mechanism of inactivation in colorectal …
repair (MMR) genes can clarify the prevalence and mechanism of inactivation in colorectal …
The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications
DC Chung, AK Rustgi - Annals of internal medicine, 2003 - acpjournals.org
Basic studies of DNA replication and repair have provided surprising and pivotal insights
into a novel pathway of tumorigenesis. Defects in the DNA mismatch repair process …
into a novel pathway of tumorigenesis. Defects in the DNA mismatch repair process …
Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age
JT Liang, KC Huang, AL Cheng, YM Jeng… - Journal of British …, 2003 - academic.oup.com
Background The aim of the present study was to identify the clinicopathological and
molecular biological characteristics of early-onset colorectal cancers. Methods The …
molecular biological characteristics of early-onset colorectal cancers. Methods The …
Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC)
A Loukola, K Eklin, P Laiho, R Salovaara, P Kristo… - Cancer research, 2001 - AACR
Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant cancer
predisposition syndrome caused by germ-line mutations in DNA mismatch repair genes. It is …
predisposition syndrome caused by germ-line mutations in DNA mismatch repair genes. It is …